Duyuru • Apr 29
Serge Ferrari Group Discontinues Pet Spinning Operations At Tersuisse Site and Reduces 62 Jobs Serge Ferrari Group announced a new phase in the rollout of its plan to streamline its industrial operations, with plans to cease operations at the Tersuisse site, its high-tenacity PET (polyethylene terephthalate) yarn production plant located in Emmenbrücke, Switzerland, which employs 62 people. Industrial continuity would be fully ensured through external supplies of PET yarn. The Group would, however, retain the intellectual property and technological expertise related to its specialty yarns. Warping operations would be transferred to the La Tour du Pin site to secure the value chain and keep key expertise at the heart of the industrial infrastructure. In line with its strategic plan, this project aims to strengthen the Group’s competitiveness and industrial flexibility to better address the accelerating pace of change in its business segments. It would result in exceptional expenses in the first half of 2026, with a limited cash impact, but would have a positive effect on operating profitability while reducing capital employed starting in 2027. Duyuru • Apr 23
SergeFerrari Group SA to Report First Half, 2026 Results on Sep 09, 2026 SergeFerrari Group SA announced that they will report first half, 2026 results on Sep 09, 2026 Duyuru • Oct 21
SergeFerrari Group SA to Report Fiscal Year 2025 Results on Mar 11, 2026 SergeFerrari Group SA announced that they will report fiscal year 2025 results After-Market on Mar 11, 2026 Duyuru • Apr 25
SergeFerrari Group SA to Report First Half, 2025 Results on Sep 10, 2025 SergeFerrari Group SA announced that they will report first half, 2025 results on Sep 10, 2025 Duyuru • Mar 29
SergeFerrari Group SA, Annual General Meeting, May 15, 2025 SergeFerrari Group SA, Annual General Meeting, May 15, 2025. Duyuru • Oct 31
SergeFerrari Group SA to Report Fiscal Year 2024 Results on Mar 27, 2025 SergeFerrari Group SA announced that they will report fiscal year 2024 results on Mar 27, 2025 Buy Or Sell Opportunity • Sep 11
Now 23% overvalued Over the last 90 days, the stock has fallen 11% to €5.45. The fair value is estimated to be €4.44, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 22%. For the next 3 years, revenue is forecast to grow by 2.5% per annum. Earnings are also forecast to grow by 42% per annum over the same time period. Upcoming Dividend • Jun 21
Upcoming dividend of €0.12 per share Eligible shareholders must have bought the stock before 28 June 2024. Payment date: 02 July 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.1%). Valuation Update With 7 Day Price Move • May 09
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to €7.21, the stock trades at a forward P/E ratio of 34x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 16% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.73 per share. New Risk • Mar 31
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 48% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.1x net interest cover). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.4% net profit margin). Market cap is less than US$100m (€69.2m market cap, or US$74.6m). Reported Earnings • Mar 28
Full year 2023 earnings released: EPS: €0.40 (vs €1.30 in FY 2022) Full year 2023 results: EPS: €0.40 (down from €1.30 in FY 2022). Revenue: €327.6m (down 3.3% from FY 2022). Net income: €4.72m (down 70% from FY 2022). Profit margin: 1.4% (down from 4.6% in FY 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Duyuru • Mar 27
SergeFerrari Group SA Proposes Dividend for Fiscal Year 2023, Payable in July 2024 SergeFerrari Group SA announced that, at the Annual General Meeting of May 16th, 2024, the Group will propose a dividend of €0.12 per share for fiscal year 2023, payable in July 2024. Duyuru • Jan 31
SergeFerrari Group SA to Report Fiscal Year 2023 Results on Mar 26, 2024 SergeFerrari Group SA announced that they will report fiscal year 2023 results After-Market on Mar 26, 2024 Valuation Update With 7 Day Price Move • Jan 23
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to €6.46, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 2.5% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €12.60 per share. New Risk • Dec 08
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 1.7% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (16% operating cash flow to total debt). Earnings are forecast to decline by an average of 1.7% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (139% cash payout ratio). Share price has been volatile over the past 3 months (8.8% average weekly change). Valuation Update With 7 Day Price Move • Nov 03
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to €5.99, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 12% over the past three years. Valuation Update With 7 Day Price Move • Oct 19
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to €6.19, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 15x in the Chemicals industry in Germany. Total returns to shareholders of 1.7% over the past three years. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to €7.87, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 16x in the Chemicals industry in Germany. Total returns to shareholders of 43% over the past three years. New Risk • Jul 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (10.0% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.9% average weekly change). Valuation Update With 7 Day Price Move • Jul 20
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to €11.96, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 93% over the past three years. Upcoming Dividend • Apr 19
Upcoming dividend of €0.40 per share at 2.8% yield Eligible shareholders must have bought the stock before 26 April 2023. Payment date: 28 April 2023. Payout ratio is a comfortable 31% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.3%). Reported Earnings • Mar 08
Full year 2022 earnings released: EPS: €1.30 (vs €0.86 in FY 2021) Full year 2022 results: EPS: €1.30 (up from €0.86 in FY 2021). Revenue: €338.7m (up 19% from FY 2021). Net income: €15.5m (up 53% from FY 2021). Profit margin: 4.6% (up from 3.6% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 2.1% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 15% share price gain to €13.22, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 12x in the Chemicals industry in Germany. Total returns to shareholders of 120% over the past three years. Valuation Update With 7 Day Price Move • Sep 24
Investor sentiment deteriorated over the past week After last week's 16% share price decline to €9.50, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 9x in the Chemicals industry in Germany. Total returns to shareholders of 8.6% over the past year. Valuation Update With 7 Day Price Move • Jul 23
Investor sentiment improved over the past week After last week's 15% share price gain to €13.76, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 8x in the Chemicals industry in Germany. Total returns to shareholders of 110% over the past year. Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment deteriorated over the past week After last week's 17% share price decline to €13.10, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 94% over the past year. Upcoming Dividend • May 12
Upcoming dividend of €0.29 per share Eligible shareholders must have bought the stock before 19 May 2022. Payment date: 23 May 2022. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of German dividend payers (4.2%). Lower than average of industry peers (5.1%). Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment improved over the past week After last week's 16% share price gain to €16.52, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 226% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.48 per share. Reported Earnings • Mar 09
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: €0.86 (up from €0.04 in FY 2020). Revenue: €285.9m (up 46% from FY 2020). Net income: €10.2m (up €9.71m from FY 2020). Profit margin: 3.6% (up from 0.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.5%. Over the next year, revenue is forecast to grow 8.8%, compared to a 4.5% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 41% per year whereas the company’s share price has increased by 40% per year. Valuation Update With 7 Day Price Move • Jan 29
Investor sentiment improved over the past week After last week's 17% share price gain to €14.80, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 159% over the past three years. Reported Earnings • Sep 11
First half 2021 earnings released: EPS €0.75 (vs €0.21 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €144.7m (up 82% from 1H 2020). Net income: €8.74m (up 245% from 1H 2020). Profit margin: 6.0% (up from 3.2% in 1H 2020). Reported Earnings • Mar 31
Full year 2020 earnings released: EPS €0.04 (vs €0.41 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: €195.3m (up 3.3% from FY 2019). Net income: €471.0k (down 90% from FY 2019). Profit margin: 0.2% (down from 2.6% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. Reported Earnings • Mar 15
Full year 2020 earnings released: EPS €0.04 (vs €0.41 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: €195.3m (up 3.3% from FY 2019). Net income: €471.0k (down 90% from FY 2019). Profit margin: 0.2% (down from 2.6% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. Is New 90 Day High Low • Feb 10
New 90-day high: €7.06 The company is up 31% from its price of €5.40 on 11 November 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €10.96 per share. Is New 90 Day High Low • Jan 22
New 90-day high: €6.62 The company is up 10.0% from its price of €6.04 on 23 October 2020. The German market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €12.16 per share. Is New 90 Day High Low • Oct 29
New 90-day low: €5.20 The company is down 7.0% from its price of €5.58 on 30 July 2020. The German market is down 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €10.95 per share. Valuation Update With 7 Day Price Move • Oct 29
Market pulls back on stock over the past week After last week's 17% share price decline to €5.20, the stock is trading at a trailing P/E ratio of 17.5x, down from the previous P/E ratio of 21.1x. This compares to an average P/E of 30x in the Chemicals industry in Germany. Total return to shareholders over the past three years is a loss of 54%.